Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
BIOCRYST PHARMACEUTICALS INC has filed 1,953 SEC EDGAR filings since 14 Feb 1995

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page
25
Current page
22
4

PRIMARY DOCUMENT

Filing date
14 May 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 May 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 May 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
13 May 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
06 May 2020
Reporting date
06 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 May 2020
Reporting date
30 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-23186

CT ORDER filing

Filing date
01 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
27 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-237820

S-3

Filing date
24 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-44055

BIOCRYST PHARMACEUTICALS INC

Filing date
17 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
10 Apr 2020
Reporting date
09 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Apr 2020
Reporting date
29 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
02 Apr 2020
Reporting date
02 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-23186

DEFA14A

Filing date
31 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-23186

DEFINITIVE PROXY STATEMENT

Filing date
31 Mar 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
30 Mar 2020
Reporting date
30 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-23186

PRELIMINARY PROXY STATEMENT

Filing date
19 Mar 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
10 Mar 2020
Reporting date
04 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
05 Mar 2020
Reporting date
05 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
05 Mar 2020
Reporting date
05 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
27 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .